• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

固体脂质纳米粒递送编码尿素酶 A 亚单位的 DNA 疫苗:感染小鼠模型前后的免疫分析。

Solid Lipid Nanoparticles Delivering a DNA Vaccine Encoding Urease A Subunit: Immune Analyses before and after a Mouse Model of Infection.

机构信息

School of Science, RMIT University, 264 Plenty Road, Bundoora, VIC 3083, Australia.

Melbourne Veterinary School, Faculty of Science, The University of Melbourne, Parkville, VIC 3010, Australia.

出版信息

Int J Mol Sci. 2024 Jan 16;25(2):1076. doi: 10.3390/ijms25021076.

DOI:10.3390/ijms25021076
PMID:38256149
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10816323/
Abstract

In this study, novel solid lipid particles containing the adjuvant lipid monophosphoryl lipid A (termed 'SLN-A') were synthesised. The SLN-A particles were able to efficiently bind and form complexes with a DNA vaccine encoding the urease alpha subunit of . The resultant nanoparticles were termed lipoplex-A. In a mouse model of infection, the lipoplex-A nanoparticles were used to immunise mice, and the resultant immune responses were analysed. It was found that the lipoplex-A vaccine was able to induce high levels of antigen-specific antibodies and an influx of gastric CD4 T cells in vaccinated mice. In particular, a prime with lipoplex-A and a boost with soluble UreA protein induced significantly high levels of the IgG1 antibody, whereas two doses of lipoplex-A induced high levels of the IgG2c antibody. In this study, lipoplex-A vaccination did not lead to a significant reduction in colonisation in a challenge model; however, these results point to the utility of the system for delivering DNA vaccine-encoded antigens to induce immune responses and suggest the ability to tailor those responses.

摘要

在这项研究中,合成了含有佐剂脂质单磷酰脂质 A(称为“SLN-A”)的新型固体脂质颗粒。这些 SLN-A 颗粒能够有效地与编码 尿素酶 α 亚单位的 DNA 疫苗结合并形成复合物。所得的纳米颗粒称为脂质体 A。在 感染的小鼠模型中,使用脂质体 A 纳米颗粒对小鼠进行免疫,并分析了产生的免疫反应。结果发现,脂质体 A 疫苗能够诱导接种小鼠产生高水平的抗原特异性抗体和胃 CD4 T 细胞涌入。特别是,脂质体 A 进行初免和可溶性 UreA 蛋白进行加强免疫可诱导高水平的 IgG1 抗体,而两剂脂质体 A 可诱导高水平的 IgG2c 抗体。在这项研究中,脂质体 A 疫苗接种并没有在挑战模型中导致定植的显著减少;然而,这些结果表明该系统用于传递 DNA 疫苗编码抗原以诱导免疫反应的有效性,并表明能够调整这些反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/10816323/822e2a129842/ijms-25-01076-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/10816323/e8d828804640/ijms-25-01076-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/10816323/3eaadf7cef6d/ijms-25-01076-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/10816323/e2f56b4284f7/ijms-25-01076-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/10816323/47804c824655/ijms-25-01076-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/10816323/46a4fb8e4b2c/ijms-25-01076-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/10816323/822e2a129842/ijms-25-01076-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/10816323/e8d828804640/ijms-25-01076-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/10816323/3eaadf7cef6d/ijms-25-01076-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/10816323/e2f56b4284f7/ijms-25-01076-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/10816323/47804c824655/ijms-25-01076-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/10816323/46a4fb8e4b2c/ijms-25-01076-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/10816323/822e2a129842/ijms-25-01076-g006.jpg

相似文献

1
Solid Lipid Nanoparticles Delivering a DNA Vaccine Encoding Urease A Subunit: Immune Analyses before and after a Mouse Model of Infection.固体脂质纳米粒递送编码尿素酶 A 亚单位的 DNA 疫苗:感染小鼠模型前后的免疫分析。
Int J Mol Sci. 2024 Jan 16;25(2):1076. doi: 10.3390/ijms25021076.
2
Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.用尿素酶B DNA疫苗进行黏膜免疫可诱导针对幽门螺杆菌的固有免疫和细胞免疫反应。
Helicobacter. 2006 Apr;11(2):113-22. doi: 10.1111/j.1523-5378.2006.00385.x.
3
Protection Against Infection in BALB/c Mouse Model by Oral Administration of Multivalent Epitope-Based Vaccine of Cholera Toxin B Subunit-HUUC.口服基于多价表位的霍乱毒素 B 亚单位-HUUC 疫苗对 BALB/c 小鼠模型的抗感染保护作用。
Front Immunol. 2018 May 8;9:1003. doi: 10.3389/fimmu.2018.01003. eCollection 2018.
4
Solid Lipid Nanoparticle Carrier Platform Containing Synthetic TLR4 Agonist Mediates Non-Viral DNA Vaccine Delivery.含有合成Toll样受体4激动剂的固体脂质纳米颗粒载体平台介导非病毒DNA疫苗递送。
Vaccines (Basel). 2020 Sep 21;8(3):551. doi: 10.3390/vaccines8030551.
5
Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on Infection in Mongolian gerbils.基于NAP、脲酶、HSP60和HpaA的多价表位疫苗经口免疫对蒙古沙鼠感染具有治疗作用。
Front Cell Infect Microbiol. 2017 Aug 4;7:349. doi: 10.3389/fcimb.2017.00349. eCollection 2017.
6
Immunological features and efficacy of a multi-epitope vaccine CTB-UE against H. pylori in BALB/c mice model.多表位疫苗CTB-UE在BALB/c小鼠模型中抗幽门螺杆菌的免疫学特征及疗效
Appl Microbiol Biotechnol. 2014 Apr;98(8):3495-507. doi: 10.1007/s00253-013-5408-6. Epub 2013 Dec 28.
7
Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.用表达多表位抗原CTB-UE的重组乳酸乳球菌进行口服免疫可减轻小鼠幽门螺杆菌感染。
Pathog Dis. 2014 Oct;72(1):78-86. doi: 10.1111/2049-632X.12173. Epub 2014 Apr 15.
8
Poliovirus replicons encoding the B subunit of Helicobacter pylori urease elicit a Th1 associated immune response.编码幽门螺杆菌脲酶B亚基的脊髓灰质炎病毒复制子引发Th1相关免疫反应。
Vaccine. 1999 May 14;17(19):2384-91. doi: 10.1016/s0264-410x(99)00035-3.
9
Expression of Helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H. pylori infection in mice.幽门螺杆菌脲酶B亚基基因在乳酸乳球菌MG1363中的表达及其作为抗小鼠幽门螺杆菌感染疫苗递送系统的应用。
Vaccine. 2001 Jul 16;19(28-29):3927-35. doi: 10.1016/s0264-410x(01)00119-0.
10
Protection against Helicobacter pylori infection in BALB/c mice by oral administration of multi-epitope vaccine of CTB-UreI-UreB.口服CTB-UreI-UreB多表位疫苗对BALB/c小鼠幽门螺杆菌感染的保护作用
Pathog Dis. 2015 Jul;73(5). doi: 10.1093/femspd/ftv026. Epub 2015 Apr 6.

引用本文的文献

1
Recent Advancements in Lipid Nanoparticles-Based Phytoactives Delivery Systems for Neurodegenerative Diseases.基于脂质纳米颗粒的神经退行性疾病植物活性成分递送系统的最新进展
Int J Nanomedicine. 2025 Aug 25;20:10279-10300. doi: 10.2147/IJN.S537566. eCollection 2025.
2
Unraveling : Insights into Pathogenesis, Immune Evasion, and Progress Toward Effective Vaccination.解析:对发病机制、免疫逃逸及有效疫苗研发进展的洞察
Vaccines (Basel). 2025 Jul 3;13(7):725. doi: 10.3390/vaccines13070725.
3
Special Issue "Recent Advances in Nanoparticles in Molecular Biology".

本文引用的文献

1
An Evaluation of Urease A Subunit Nanocapsules as a Vaccine in a Mouse Model of Infection.脲酶A亚基纳米胶囊作为感染小鼠模型疫苗的评估
Vaccines (Basel). 2023 Oct 27;11(11):1652. doi: 10.3390/vaccines11111652.
2
Prophylactic immunization to Helicobacter pylori infection using spore vectored vaccines.预防性免疫幽门螺杆菌感染的孢子载体疫苗。
Helicobacter. 2023 Aug;28(4):e12997. doi: 10.1111/hel.12997. Epub 2023 Jun 14.
3
Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India.
特刊“纳米颗粒在分子生物学中的最新进展”
Int J Mol Sci. 2025 Jun 30;26(13):6321. doi: 10.3390/ijms26136321.
4
Vaccine: Mechanism of Pathogenesis, Immune Evasion and Analysis of Vaccine Types.疫苗:发病机制、免疫逃逸及疫苗类型分析
Vaccines (Basel). 2025 May 15;13(5):526. doi: 10.3390/vaccines13050526.
5
Chitosan Nanoparticles for Enhanced Immune Response and Delivery of Multi-Epitope Vaccines in a BALB/c Mouse Model.壳聚糖纳米颗粒增强BALB/c小鼠模型的免疫反应及多表位疫苗递送
Pharmaceutics. 2025 Jan 18;17(1):132. doi: 10.3390/pharmaceutics17010132.
6
Adjuvants for vaccines: Outer membrane vesicles provide an alternative strategy.疫苗佐剂:外膜囊泡提供了一种替代策略。
Virulence. 2024 Dec;15(1):2425773. doi: 10.1080/21505594.2024.2425773. Epub 2024 Nov 20.
7
Lipoplexes' Structure, Preparation, and Role in Managing Different Diseases.脂质体的结构、制备及其在治疗多种疾病中的作用。
AAPS PharmSciTech. 2024 Jun 7;25(5):131. doi: 10.1208/s12249-024-02850-6.
8
Nanocapsules Comprised of Purified Protein: Construction and Applications in Vaccine Research.由纯化蛋白组成的纳米胶囊:构建及其在疫苗研究中的应用
Vaccines (Basel). 2024 Apr 12;12(4):410. doi: 10.3390/vaccines12040410.
DNA SARS-CoV-2 疫苗(ZyCoV-D)的有效性、安全性和免疫原性:在印度进行的 3 期、随机、双盲、安慰剂对照研究的中期疗效结果。
Lancet. 2022 Apr 2;399(10332):1313-1321. doi: 10.1016/S0140-6736(22)00151-9.
4
Design and Preparation of Solid Lipid Nanoparticle (SLN)-Mediated DNA Vaccines.固体脂质纳米粒(SLN)介导的 DNA 疫苗的设计与制备。
Methods Mol Biol. 2022;2412:355-366. doi: 10.1007/978-1-0716-1892-9_18.
5
Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models.DNA 疫苗候选物 ZyCoV-D 对动物模型中 SARS-CoV-2 的免疫原性。
Vaccine. 2021 Jul 5;39(30):4108-4116. doi: 10.1016/j.vaccine.2021.05.098. Epub 2021 Jun 1.
6
Emerging concepts in the science of vaccine adjuvants.疫苗佐剂科学中的新观点。
Nat Rev Drug Discov. 2021 Jun;20(6):454-475. doi: 10.1038/s41573-021-00163-y. Epub 2021 Apr 6.
7
Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates.异源初免-加强:突破 COVID-19 候选疫苗保护性免疫应答瓶颈。
Emerg Microbes Infect. 2021 Dec;10(1):629-637. doi: 10.1080/22221751.2021.1902245.
8
MPL Adjuvant Contains Competitive Antagonists of Human TLR4.MPL 佐剂含有人 TLR4 的竞争性拮抗剂。
Front Immunol. 2020 Oct 16;11:577823. doi: 10.3389/fimmu.2020.577823. eCollection 2020.
9
Solid Lipid Nanoparticle Carrier Platform Containing Synthetic TLR4 Agonist Mediates Non-Viral DNA Vaccine Delivery.含有合成Toll样受体4激动剂的固体脂质纳米颗粒载体平台介导非病毒DNA疫苗递送。
Vaccines (Basel). 2020 Sep 21;8(3):551. doi: 10.3390/vaccines8030551.
10
DNA vaccines: prime time is now.DNA 疫苗:现在是黄金时期。
Curr Opin Immunol. 2020 Aug;65:21-27. doi: 10.1016/j.coi.2020.01.006. Epub 2020 Apr 4.